Proposed US tariffs on patented drugs may pressure innovators to shift production locally, creating uncertainty for Indian CDMOs even as generics-led exports remain largely insulated
Proposed US tariffs on patented drugs may pressure innovators to shift production locally, creating uncertainty for Indian CDMOs even as generics-led exports remain largely insulated